These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 8893275)

  • 1. Transdermal delivery of fentanyl by electroporation. II. Mechanisms involved in drug transport.
    Vanbever R; Morre ND; Préat V
    Pharm Res; 1996 Sep; 13(9):1360-6. PubMed ID: 8893275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transdermal delivery of fentanyl by electroporation. I. Influence of electrical factors.
    Vanbever R; LeBoulengé E; Préat V
    Pharm Res; 1996 Apr; 13(4):559-65. PubMed ID: 8710746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transdermal delivery of fentanyl: rapid onset of analgesia using skin electroporation.
    Vanbever R; Langers G; Montmayeur S; Préat V
    J Control Release; 1998 Jan; 50(1-3):225-35. PubMed ID: 9685889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrically modulated transdermal delivery of fentanyl.
    Conjeevaram R; Banga AK; Zhang L
    Pharm Res; 2002 Apr; 19(4):440-4. PubMed ID: 12033377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of a phosphorothioate oligonucleotide delivery by skin electroporation.
    Regnier V; De Morre N; Jadoul A; Préat V
    Int J Pharm; 1999 Jul; 184(2):147-56. PubMed ID: 10387943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transdermal delivery of metoprolol by electroporation.
    Vanbever R; Lecouturier N; Préat V
    Pharm Res; 1994 Nov; 11(11):1657-62. PubMed ID: 7870686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macromolecules as novel transdermal transport enhancers for skin electroporation.
    Vanbever R; Prausnitz MR; Préat V
    Pharm Res; 1997 May; 14(5):638-44. PubMed ID: 9165536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transdermal drug delivery using electroporation. I. Factors influencing in vitro delivery of terazosin hydrochloride in hairless rats.
    Sharma A; Kara M; Smith FR; Krishnan TR
    J Pharm Sci; 2000 Apr; 89(4):528-35. PubMed ID: 10737914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transdermal delivery of nalbuphine and its prodrugs by electroporation.
    Sung KC; Fang JY; Wang JJ; Hu OY
    Eur J Pharm Sci; 2003 Jan; 18(1):63-70. PubMed ID: 12554074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transdermal permeation of neutral molecules by skin electroporation.
    Vanbever R; Leroy MA; Préat V
    J Control Release; 1998 Aug; 54(3):243-50. PubMed ID: 9766244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo real-time monitoring system of electroporation mediated control of transdermal and topical drug delivery.
    Blagus T; Markelc B; Cemazar M; Kosjek T; Preat V; Miklavcic D; Sersa G
    J Control Release; 2013 Dec; 172(3):862-71. PubMed ID: 24113487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transdermal delivery of timolol by electroporation through human skin.
    Denet AR; Préat V
    J Control Release; 2003 Mar; 88(2):253-62. PubMed ID: 12628332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skin electroporation for transdermal drug delivery: the influence of the order of different square wave electric pulses.
    Zorec B; Becker S; Reberšek M; Miklavčič D; Pavšelj N
    Int J Pharm; 2013 Nov; 457(1):214-23. PubMed ID: 24076397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro study of low-frequency ultrasound-enhanced transdermal transport of fentanyl and caffeine across human and hairless rat skin.
    Boucaud A; Machet L; Arbeille B; Machet MC; Sournac M; Mavon A; Patat F; Vaillant L
    Int J Pharm; 2001 Oct; 228(1-2):69-77. PubMed ID: 11576769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parameters controlling topical delivery of oligonucleotides by electroporation.
    Regnier V; Le Doan T; Préat V
    J Drug Target; 1998; 5(4):275-89. PubMed ID: 9713977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced transdermal delivery of tetracaine by electroporation.
    Hu Q; Liang W; Bao J; Ping Q
    Int J Pharm; 2000 Jul; 202(1-2):121-4. PubMed ID: 10915934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transdermal drug delivery using electroporation. II. Factors influencing skin reversibility in electroporative delivery of terazosin hydrochloride in hairless rats.
    Sharma A; Kara M; Smith FR; Krishnan TR
    J Pharm Sci; 2000 Apr; 89(4):536-44. PubMed ID: 10737915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transdermal delivery of macromolecules using skin electroporation.
    Lombry C; Dujardin N; Préat V
    Pharm Res; 2000 Jan; 17(1):32-7. PubMed ID: 10714605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of application voltage and cathode and anode positions at electroporation on the in vitro permeation of benzoic acid through hairless rat skin.
    Yoshida M; Mori K; Watanabe T; Hasegawa T; Sugibayash K
    Chem Pharm Bull (Tokyo); 2000 Nov; 48(11):1807-9. PubMed ID: 11086923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Skin electroporation for transdermal and topical delivery.
    Denet AR; Vanbever R; Préat V
    Adv Drug Deliv Rev; 2004 Mar; 56(5):659-74. PubMed ID: 15019751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.